Corporate News
Achieve Life Sciences (ACHV)
- Trading activity: The stock closed at a 24‑hour period ending 09:07 PM Central Europe on Thursday, 22 September 2026, with no net change (0 %).
- Price: One share is currently available for approximately USD 6.47 on major exchanges.
- Shares outstanding: 102.9 million.
- Market capitalization: USD 669.9 million.
- Volume: Approximately USD 16.1 million of shares were traded in the last 24 hours.
- Performance: Since the end of last month, the share price has declined by 19.83 %.
- Technical indicators:
- 200‑day simple moving average: USD 5.59.
- 52‑week high: USD 8.64 (recorded on 09/03/2026).
- 52‑week low: USD 2.62 (recorded on 03/30/2026).
Related stocks – 24‑hour performance
| Symbol | Current price | 24‑hour change | Market cap (USD mn) | Notable news |
|---|---|---|---|---|
| EVLV | USD 4.55 | +3.27 % | 795 | Leadership change: Matt Gennone appointed CEO of Evolv Technologies Holdings’ consulting arm. |
| PSEC‑PA | USD 14.23 | –2.8 % | 795.4 | Schedule 13D/A amendment reporting significant ownership by John F. Barry III and the John & Daria Barry Foundation. |
| GERN | USD 1.14 | –6.45 % | 796.7 | No material change noted. |
| VRTS | USD 122.18 | –0.57 % | 795.3 | No material change noted. |
| APMD | USD 18.82 | +2.11 % | 793.7 | No material change noted. |
Company overview – Achieve Life Sciences
Achieve Life Sciences, Inc. is a biotechnology company focused on the development and commercialization of cytisine-based therapies for nicotine addiction. The company operates in the health‑care sector and serves customers primarily in North America. Achieve Life Sciences is listed on the Nasdaq stock exchange. Further information is available on the company website at www.achievelifesciences.com .